Patent classifications
C08G65/2633
Cyclic Amide Initialized Polyetheramine and Uses Thereof
The present disclosure provides a polyetheramine produced from a cyclic amide initiator which is first alkoxylated and then reductively aminated to form the polyetheramine. The polyetheramine of the present disclosure may be used in a variety of applications, such as a raw material in the synthesis of a dispersant for use in an aqueous pigment dispersion or as a fuel additive in a hydrocarbon fuel composition.
CO.SUB.2.-philic crosslinked polyethylene glycol-based membranes for acid and sour gas separations
This disclosure relates to CO.sub.2-philic crosslinked polyethylene glycol membranes useful for natural gas purification processes. Also provided are methods of using the membranes to remove CO.sub.2 and H.sub.2S from natural gas.
CO2-PHILIC CROSSLINKED POLYETHYLENE GLYCOL-BASED MEMBRANES FOR ACID AND SOUR GAS SEPARATIONS
This disclosure relates to CO.sub.2-philic crosslinked polyethylene glycol membranes useful for natural gas purification processes. Also provided are methods of using the membranes to remove CO.sub.2 and H.sub.2S from natural gas.
CO2-PHILIC CROSSLINKED POLYETHYLENE GLYCOL-BASED MEMBRANES FOR ACID AND SOUR GAS SEPARATIONS
This disclosure relates to CO.sub.2-philic crosslinked polyethylene glycol membranes useful for natural gas purification processes. Also provided are methods of using the membranes to remove CO.sub.2 and H.sub.2S from natural gas.
(POLY)ALKYLENE GLYCOL-CONTAINING COMPOUND
The present invention provides a (poly)alkylene glycol-containing compound having higher detergency for composite stains of hydrophilic stains and hydrophobic stains than conventional (poly)alkylene glycol-containing compounds. The present invention relates to a (poly)alkylene glycol-containing compound including: a hydrophobic structural moiety (A); a (poly)alkylene glycol moiety (B); and one lactam ring-containing structural unit (C), in its structure, the hydrophobic structural moiety (A) being present in a proportion of 2.5 to 60% by mass in 100% by mass of the (poly)alkylene glycol-containing compound.
COMPOSITE PARTICLES AND PRODUCTION METHOD THEREFOR
A composite particle is provided having sufficient insulating properties and high thermal conductivity and also having an excellent handling property and moldability. In particular, a random-shaped composite particle is provided in which primary particles of inorganic filler are aggregated and the primary particles are coated with a thermoplastic resin, and a method for producing the composite particle, as well as a molded article and a method for producing the molded article, are also provided.
POLYALKYLENE GLYCOL-CONTAINING COMPOUND
The present invention provides a polyalkylene glycol-containing compound having higher detergency than conventional polyalkylene glycol-containing compounds. The present invention relates to a polyalkylene glycol-containing compound represented by the following formula (1-1).
##STR00001##
SELF-GROWING DECORATIVE STICKER
In a first aspect, the present disclosure relates to a decorative patch, wherein the decorative patch comprises a first layer and a transparent second layer, wherein the first layer and transparent second layer form a first structure comprising at least one cavity, wherein the at least one cavity comprises an aqueous fluid, and wherein the aqueous fluid comprises a plurality of chloroplasts, a glucose oxidase for converting glucose to gluconolactone, and a monomer or oligomer capable of reacting with gluconolactone.
POLYPHENYLENE ETHER BISMALEIMIDE RESIN
A polyphenylene ether bismaleimide resin is provided. The polyphenylene ether bismaleimide resin (PPE-BMI) is formed from a modified polyphenylene ether diamine and a maleic anhydride by a condensation polymerization. The modified polyphenylene ether diamine is formed by reacting a phenol-based compound with a polyphenylene ether.
PHARMACEUTICAL AGENT FOR IRON CHELATING
The invention relates to a pharmaceutical agent for the complexation of iron. The pharmaceutical agent includes an initiator group, a polymer and a terminal group R.sup.7, and has the structure: initiator group-polymer-R.sup.7. The pharmaceutical agent further includes one or more functional hydroxamic acid groups of the type (CO)NHOH or (CO)NCH.sub.3OH.